DCLK1 and neoplasm: After a 16-day treatment via gavage administration (25 mg/kg, every other day), we observed a significant reduction in tumor size (Fig. 8I), tumor weight (Fig. 8J), and growth rate (Fig. 8K) in the DCLK1-IN-1 group.